LYRA · Lyra Therapeutics, Inc.
$0.50
+0.00 (+0.00%)
At close · Jul 28
Going-concern doubt
— flagged Mar 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our recurring losses from operations raise substantial doubt regarding our ability to continue as a going concern”View the 10-K filed Mar 31, 2026
Market Cap
$887,441
Shares
1.77M
Lyra Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Lyra Therapeutics, Inc. (LYRA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY25 · Q1
2025-06-02
Lyra Therapeutics, Inc. Q1 FY2025 Earnings Call
Revenue
$183,000
▼ 65.6% YoY Diluted EPS
$-6.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q3
2021-11-09
Lyra Therapeutics, Inc. Q3 FY2021 Earnings Call
Revenue
$14,000
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Lyra Therapeutics, Inc. Q2 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Lyra Therapeutics, Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-09
Lyra Therapeutics, Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q2
2020-08-05
Lyra Therapeutics, Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–6 of 6 earnings calls